Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters.

OBJECTIVES To investigate the role of Major Facilitator Superfamily (MFS)-type transporters from Acinetobacter baumannii AYE in tigecycline efflux. METHODS Two putative tetracycline transporter genes of A. baumannii AYE (tetA and tetG) were heterologously expressed in Escherichia coli and drug susceptibility assays were conducted with tigecycline and three other tetracycline derivatives. The importance of TetA in tigecycline transport in A. baumannii was determined by complementation of tetA in WT and Resistance Nodulation cell Division (RND) gene knockout strains of A. baumannii ATCC 19606. Gene expression of the MFS-type tetA gene and RND efflux pump genes adeB, adeG and adeJ in A. baumannii AYE in the presence of tigecycline was analysed by quantitative real-time RT-PCR. RESULTS Overproduction of TetA or TetG conferred resistance to doxycycline, minocycline and tetracycline in E. coli. Cells expressing tetA, but not those expressing tetG, conferred resistance to tigecycline, implying that TetA is a determinant for tigecycline transport. A. baumannii WT and RND-knockout strains complemented with plasmid-encoded tetA are significantly less susceptible to tigecycline compared with non-complemented strains. Efflux pump genes tetA and adeG are up-regulated in A. baumannii AYE in the presence of subinhibitory tigecycline concentrations. CONCLUSIONS TetA plays an important role in tigecycline efflux of A. baumannii by removing the drug from cytoplasm to periplasm and, subsequently, the RND-type transporters AdeABC and AdeIJK extrude tigecycline across the outer membrane. When challenged with tigecycline, tetA is up-regulated in A. baumannii AYE. Synergy between TetA and the RND-type transporters AdeABC and/or AdeIJK appears necessary for A. baumannii to confer higher tigecycline resistance via drug efflux.

[1]  Christian Lesterlin,et al.  Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer , 2019, Science.

[2]  B. Averhoff,et al.  The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity , 2019, The Journal of antimicrobial chemotherapy.

[3]  M. Dunlop,et al.  Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation , 2018, Science.

[4]  Yonghong Xiao,et al.  Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach , 2016, Scientific Reports.

[5]  D. Andersson,et al.  Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance , 2015, Antimicrobial Agents and Chemotherapy.

[6]  Nikolaos A. Triarides,et al.  Tetracyclines for multidrug-resistant Acinetobacter baumannii infections. , 2015, International journal of antimicrobial agents.

[7]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[8]  P. Courvalin,et al.  RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations , 2013, Antimicrobial Agents and Chemotherapy.

[9]  P. Courvalin,et al.  Efflux-Mediated Antibiotic Resistance in Acinetobacter spp , 2010, Antimicrobial Agents and Chemotherapy.

[10]  J. Quinn,et al.  AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[11]  S. Schuldiner,et al.  A coordinated network of transporters with overlapping specificities provides a robust survival strategy , 2009, Proceedings of the National Academy of Sciences.

[12]  D. Paterson,et al.  Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.

[13]  P. Vincent,et al.  Multidrug Resistance Pump Acrab-tolc Is Required for High-level, Tet(a)-mediated Tetracycline Resistance in Escherichia Coli , 2022 .

[14]  A. Yamaguchi,et al.  Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936) , 2004, Antimicrobial Agents and Chemotherapy.

[15]  J. Ruiz,et al.  Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. , 2003, The Journal of antimicrobial chemotherapy.

[16]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[17]  Jean Swings,et al.  Distribution of Oxytetracycline Resistance Plasmids between Aeromonads in Hospital and Aquaculture Environments: Implication of Tn1721 in Dissemination of the Tetracycline Resistance Determinant Tet A , 2000, Applied and Environmental Microbiology.

[18]  Angela Lee,et al.  Interplay between Efflux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance , 2000, Journal of bacteriology.

[19]  S. Schwarz,et al.  Plasmid-encoded tetracycline resistance in Salmonella enterica subsp. enterica serovars choleraesuis and typhimurium: identification of complete and truncated Tn1721 elements. , 1999, FEMS microbiology letters.

[20]  N. Jacobus,et al.  In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936) , 1999, Antimicrobial Agents and Chemotherapy.